FierceBiotechOriginal article
{"a":[{"_":"Smith & Nephew cuts 2026 outlook as US knee implant sales slide","$":{"href":"/medtech/smith-nephew-cuts-2026-outlook-us-knee-implant-sales-slide","hreflang":"en"}}]}
EarningsNegative
AI Analysis
Summary
Smith & Nephew has lowered its 2026 sales outlook due to weakness in U.S. orthopedics and wound care, despite stronger growth in sports medicine.
Financial Highlights
Guidance
lowered 2026 sales outlook
Importance:5/10
Sentiment:
-0.70
orthopedicsknee implantswound caresports medicineguidance reductionUS market weakness
Related Companies
Read the original article
Published by FierceBiotech on August 4, 2026 11:23 AM
